Details of the Drug

General Information of Drug (ID: DM7QG0M)

Drug Name
Raxibacumab
Indication
Disease Entry ICD 11 Status REF
Anthrax 1B97 Approved [1]
Affected Organisms
Gram-positive Bacteria
ATC Code
J06BC02: Raxibacumab
J06BC: Antibacterial monoclonal antibodies
J06B: IMMUNOGLOBULINS
J06: IMMUNE SERA AND IMMUNOGLOBULINS
J: ANTIINFECTIVES FOR SYSTEMIC USE
Drug Type
Monoclonal antibody
ADMET Property
Half-life
The concentration or amount of drug in body reduced by one-half in 15 - 19 days [2]
Cross-matching ID
UNII
794PGL549S
DrugBank ID
DB08902
TTD ID
D02JYA

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Protective antigen (Bact pagA) TT3YGCD PAG_BACAN Modulator [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011 Apr 1;186(7):4234-43.
2 Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds